Compass Capital Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Sell
2,628
-276
-10% -$282K 1.04% 20
2026
Q1
$2.82M Buy
2,904
+201
+7% +$204K 1.01% 25
2025
Q4
$2.77M Buy
2,703
+9
+0.3% +$8.61K 1.07% 23
2025
Q3
$2.64M Sell
2,694
-78
-3% -$58K 1.15% 23
2025
Q2
$2.16M Buy
2,772
+197
+8% +$153K 1.02% 29
2025
Q1
$2.09M Sell
2,575
-99
-4% -$82.4K 1.1% 26
2024
Q4
$2.06M Buy
+2,674
New +$2.21M 0.8% 36

Other funds holding LLY

Compass Capital Corp's LLY Position: Q2 2026 in Review

Compass Capital Corp reduced its Eli Lilly (LLY) stake by 9.5% in Q2 2026, selling an estimated $282K and leaving 2,628 shares worth $3.19M. The position accounts for 1.04% of the portfolio, ranked #20.

Compass Capital Corp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Compass Capital Corp held 2,628 shares of Eli Lilly worth $3.19M as of Q2 2026.
  • Compass Capital Corp sold 276 Eli Lilly shares in Q2 2026, an estimated $282K.
  • Eli Lilly made up 1.04% of Compass Capital Corp's portfolio in Q2 2026, its #20 holding.
  • Compass Capital Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.